Department of Clinical Pharmacology, Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT00707226
After focusing many years only on intraocular pressure (IOP) as the primary risk factor, recently the impact of ocular blood flow is getting more consideration for the pathophysiology of glaucoma. The circadian change of intraocular pressure (IOP) is well investigated, but diurnal variations in ocular blood flow are yet to be evaluated, especially in glaucomatous eyes.
This study is performed to investigate circadian variation of ocular blood flow assessed by laser interferometric fundus pulsation amplitude (FPA) and laser Doppler flowmetry (LDF) in glaucomatous eyes during topical antiglaucoma therapy at 8:00, 12:00, 17:00 and 21:00, to compare these circadian variation of ocular blood flow in glaucomatous eyes with variations in healthy eyes and to relate blood flow variations with IOP variations.
Looking for future studies?
Notify MeMale
Observational
Vienna, 1090, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For the glaucoma patients:
For the age matched control subjects:
Exclusion criteria
For the glaucoma patients:
For the age matched control subjects:
Time frame: 13 hours
Time frame: 13 hours
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03624361
Eye Diseases, Glaucoma
Grenoble, France
View Trial DetailsNCT04297930
Eye Diseases, Glaucoma
Singapore
View Trial DetailsNCT04202562
Cardiovascular Diseases, Cataract
Madrid, Spain
View Trial DetailsNCT05236439
Eye Diseases, Glaucoma
Yerevan, Armenia
View Trial Details